|
1
|
Shoshan-Barmatz V, Pittala S and Mizrachi
D: VDAC1 and the TSPO: Expression, Interactions, and associated
functions in health and disease states. Int J Mol Sci. 20:33482019.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Braestrup C and Squires RF: Specific
benzodiazepine receptors in rat brain characterized by
high-affinity (3H)diazepam binding. Proc Natl Acad Sci USA.
74:3805–3809. 1977. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Papadopoulos V, Baraldi M, Guilarte TR,
Knudsen TB, Lacapère JJ, Lindemann P, Norenberg MD, Nutt D, Weizman
A, Zhang MR and Gavish M: Translocator protein (18kDa): New
nomenclature for the peripheral-type benzodiazepine receptor based
on its structure and molecular function. Trends Pharmacol Sci.
27:402–409. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Tu LN, Zhao AH, Hussein M, Stocco DM and
Selvaraj V: Translocator Protein (TSPO) affects mitochondrial fatty
acid oxidation in steroidogenic cells. Endocrinology.
157:1110–1121. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Bonsack F and Sukumari-Ramesh S: TSPO: An
evolutionarily conserved protein with elusive functions. Int J Mol
Sci. 19:16942018. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Fan J and Papadopoulos V: Mitochondrial
TSPO deficiency triggers retrograde signaling in MA-10 mouse tumor
leydig cells. Int J Mol Sci. 22:2522020. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Vainshtein A, Veenman L, Shterenberg A,
Singh S, Masarwa A, Dutta B, Island B, Tsoglin E, Levin E,
Leschiner S, et al: Quinazoline-based tricyclic compounds that
regulate programmed cell death, induce neuronal differentiation,
and are curative in animal models for excitotoxicity and hereditary
brain disease. Cell Death Discov. 1:150272015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Sileikyte J, Blachly-Dyson E, Sewell R,
Carpi A, Menabò R, Di Lisa F, Ricchelli F, Bernardi P and Forte M:
Regulation of the mitochondrial permeability transition pore by the
outer membrane does not involve the peripheral benzodiazepine
receptor (Translocator Protein of 18 kDa (TSPO)). J Biol Chem.
289:13769–13781. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ilkan Z and Akar FG: The mitochondrial
translocator protein and the emerging link between oxidative stress
and arrhythmias in the diabetic heart. Front Physiol. 9:15182018.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Arbo BD, Ribeiro MF and Garcia-Segura LM:
Development of new treatments for Alzheimer's disease based on the
modulation of translocator protein (TSPO). Ageing Res Rev.
54:1009432019. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Mitro N, Cermenati G, Giatti S, Abbiati F,
Pesaresi M, Calabrese D, Garcia-Segura LM, Caruso D and Melcangi
RC: LXR and TSPO as new therapeutic targets to increase the levels
of neuroactive steroids in the central nervous system of diabetic
animals. Neurochem Int. 60:616–621. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Veenman L and Gavish M: The
peripheral-type benzodiazepine receptor and the cardiovascular
system. Implications for drug development. Pharmacol Ther.
110:503–524. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Barron AM, Garcia-Segura LM, Caruso D,
Jayaraman A, Lee JW, Melcangi RC and Pike CJ: Ligand for
translocator protein reverses pathology in a mouse model of
Alzheimer's disease. J Neurosci. 33:8891–8897. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Daugherty DJ, Selvaraj V, Chechneva OV,
Liu XB, Pleasure DE and Deng W: A TSPO ligand is protective in a
mouse model of multiple sclerosis. EMBO Mol Med. 5:891–903. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wu LP, Gong ZF, Wang H, Zhou ZS, Zhang MM,
Liu C, Ren HM, Yang J, Han Y and Zeng CY: TSPO ligands prevent the
proliferation of vascular smooth muscle cells and attenuate
neointima formation through AMPK activation. Acta Pharmacol Sin.
41:34–46. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wang M, Wang X, Zhao L, Ma W, Rodriguez
IR, Fariss RN and Wong WT: Macroglia-microglia interactions via
TSPO signaling regulates microglial activation in the mouse retina.
J Neurosci. 34:3793–3806. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Biswas L, Zhou X, Dhillon B, Graham A and
Shu X: Retinal pigment epithelium cholesterol efflux mediated by
the 18 kDa translocator protein, TSPO, a potential target for
treating age-related macular degeneration. Hum Mol Genet.
26:4327–4339. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Mages K, Grassmann F, Jagle H, Rupprecht
R, Weber BHF, Hauck SM and Grosche A: The agonistic TSPO ligand
XBD173 attenuates the glial response thereby protecting inner
retinal neurons in a murine model of retinal ischemia. J
Neuroinflammation. 16:432019. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Guo Y, Sun Z, Wang L, Jiang R, Shu Q and
Xu G: Increased expression of TSPO-VDAC complex is correlated with
NLRP3 inflammasome activation in diabetic retinopathy. Mol Med Rep.
26:3532022. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhou Y, Ou Y, Ju Z, Zhang X, Zheng L, Li
J, Sun Y and Liu X: Visualization of translocator protein (18 kDa)
(TSPO) in the retina of diabetic retinopathy rats using
fluorine-18-DPA-714. Ann Nucl Med. 34:675–681. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Lacapere JJ, Duma L, Finet S, Kassiou M
and Papadopoulos V: Insight into the Structural Features of TSPO:
Implications for drug development. Trends Pharmacol Sci.
41:110–122. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Papadopoulos V, Aghazadeh Y, Fan J,
Campioli E, Zirkin B and Midzak A: Translocator protein-mediated
pharmacology of cholesterol transport and steroidogenesis. Mol Cell
Endocrinol. 408:90–98. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Jaremko M, Jaremko L, Jaipuria G, Becker S
and Zweckstetter M: Structure of the mammalian TSPO/PBR protein.
Biochem Soc Trans. 43:566–571. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Rupprecht R, Papadopoulos V, Rammes G,
Baghai TC, Fan J, Akula N, Groyer G, Adams D and Schumacher M:
Translocator protein (18 kDa) (TSPO) as a therapeutic target for
neurological and psychiatric disorders. Nat Rev Drug Discov.
9:971–988. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Biswas L, Farhan F, Reilly J, Bartholomew
C and Shu X: TSPO ligands promote cholesterol efflux and suppress
oxidative stress and inflammation in choroidal endothelial cells.
Int J Mol Sci. 19:37402018. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Jaremko L, Jaremko M, Giller K, Becker S
and Zweckstetter M: Structure of the mitochondrial translocator
protein in complex with a diagnostic ligand. Science.
343:1363–1366. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Morohaku K, Pelton SH, Daugherty DJ,
Butler WR, Deng W and Selvaraj V: Translocator protein/peripheral
benzodiazepine receptor is not required for steroid hormone
biosynthesis. Endocrinology. 155:89–97. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Tu LN, Morohaku K, Manna PR, Pelton SH,
Butler WR, Stocco DM and Selvaraj V: Peripheral benzodiazepine
receptor/translocator protein global knock-out mice are viable with
no effects on steroid hormone biosynthesis. J Biol Chem.
289:27444–27454. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Tu LN, Zhao AH, Stocco DM and Selvaraj V:
PK11195 effect on steroidogenesis is not mediated through the
translocator protein (TSPO). Endocrinology. 156:1033–1039. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Zhao AH, Tu LN, Mukai C, Sirivelu MP,
Pillai VV, Morohaku K, Cohen R and Selvaraj V: Mitochondrial
translocator protein (TSPO) function is not essential for heme
biosynthesis. J Biol Chem. 291:1591–1603. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Casellas P, Galiegue S and Basile AS:
Peripheral benzodiazepine receptors and mitochondrial function.
Neurochem Int. 40:475–486. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Corsi L, Geminiani E and Baraldi M:
Peripheral benzodiazepine receptor (PBR) new insight in cell
proliferation and cell differentiation review. Curr Clin Pharmacol.
3:38–45. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Gatliff J, East D, Crosby J, Abeti R,
Harvey R, Craigen W, Parker P and Campanella M: TSPO interacts with
VDAC1 and triggers a ROS-mediated inhibition of mitochondrial
quality control. Autophagy. 10:2279–2296. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Varga B, Marko K, Hadinger N, Jelitai M,
Demeter K, Tihanyi K, Vas A and Madarász E: Translocator protein
(TSPO 18kDa) is expressed by neural stem and neuronal precursor
cells. Neurosci Lett. 462:257–262. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Veenman L and Gavish M: The role of 18 kDa
mitochondrial translocator protein (TSPO) in programmed cell death,
and effects of steroids on TSPO expression. Curr Mol Med.
12:398–412. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Bernardi P, Carraro M and Lippe G: The
mitochondrial permeability transition: Recent progress and open
questions. FEBS J. 289:7051–7074. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Loth MK, Guariglia SR, Re DB, Perez J, de
Paiva VN, Dziedzic JL, Chambers JW, Azzam DJ and Guilarte TR: A
novel interaction of translocator protein 18 kDa (TSPO) with NADPH
oxidase in microglia. Mol Neurobiol. 57:4467–4487. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Gatliff J, East DA, Singh A, Alvarez MS,
Frison M, Matic I, Ferraina C, Sampson N, Turkheimer F and
Campanella M: A role for TSPO in mitochondrial Ca2+
homeostasis and redox stress signaling. Cell Death Dis.
8:e28962017. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Zeno S, Veenman L, Katz Y, Bode J, Gavish
M and Zaaroor M: The 18 kDa mitochondrial translocator protein
(TSPO) prevents accumulation of protoporphyrin IX. Involvement of
reactive oxygen species (ROS). Curr Mol Med. 12:494–501. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Wolf A, Herb M, Schramm M and Langmann T:
The TSPO-NOX1 axis controls phagocyte-triggered pathological
angiogenesis in the eye. Nat Commun. 11:27092020. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Rupprecht R, Rammes G, Eser D, Baghai TC,
Schüle C, Nothdurfter C, Troxler T, Gentsch C, Kalkman HO, Chaperon
F, et al: Translocator protein (18 kD) as target for anxiolytics
without benzodiazepine-like side effects. Science. 325:490–493.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Barresi E, Robello M, Costa B, Da Pozzo E,
Baglini E, Salerno S, Da Settimo F, Martini C and Taliani S: An
update into the medicinal chemistry of translocator protein (TSPO)
ligands. Eur J Med Chem. 209:1129242021. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Gut P: Targeting mitochondrial energy
metabolism with TSPO ligands. Biochem Soc Trans. 43:537–542. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Taketani S, Kohno H, Furukawa T and
Tokunaga R: Involvement of peripheral-type benzodiazepine receptors
in the intracellular transport of heme and porphyrins. J Biochem.
117:875–880. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Snyder SH, Verma A and Trifiletti RR: The
peripheral-type benzodiazepine receptor: A protein of mitochondrial
outer membranes utilizing porphyrins as endogenous ligands. FASEB
J. 1:282–288. 1987. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Veenman L, Vainshtein A, Yasin N, Azrad M
and Gavish M: Tetrapyrroles as endogenous TSPO ligands in
eukaryotes and prokaryotes: Comparisons with synthetic ligands. Int
J Mol Sci. 17:8802016. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Tonon MC, Vaudry H, Chuquet J, Guillebaud
F, Fan J, Masmoudi-Kouki O, Vaudry D, Lanfray D, Morin F, Prevot V,
et al: Endozepines and their receptors: Structure, functions and
pathophysiological significance. Pharmacol Ther. 208:1073862020.
View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Ma Z, An R, Chen M, Wang X and Zhu M:
Random versus Block Glycopolymers bearing betulin and porphyrin for
enhanced photodynamic therapy. Biomacromolecules. 23:5074–5083.
2022. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Yamamoto M, Arimura H, Fukushige T, Minami
K, Nishizawa Y, Tanimoto A, Kanekura T, Nakagawa M, Akiyama S and
Furukawa T: Abcb10 role in heme biosynthesis in vivo: Abcb10
knockout in mice causes anemia with protoporphyrin IX and iron
accumulation. Mol Cell Biol. 34:1077–1084. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Batoko H, Veljanovski V and Jurkiewicz P:
Enigmatic Translocator protein (TSPO) and cellular stress
regulation. Trends Biochem Sci. 40:497–503. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Korolnek T and Hamza I: Like iron in the
blood of the people: The requirement for heme trafficking in iron
metabolism. Front Pharmacol. 5:1262014. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Chauveau F, Boutin H, Van Camp N, Dolle F
and Tavitian B: Nuclear imaging of neuroinflammation: A
comprehensive review of [11C]PK11195 challengers. Eur J Nucl Med
Mol Imaging. 35:2304–2319. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Dolle F, Luus C, Reynolds A and Kassiou M:
Radiolabelled molecules for imaging the translocator protein (18
kDa) using positron emission tomography. Curr Med Chem.
16:2899–2923. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Fan Z, Calsolaro V, Atkinson RA,
Femminella GD, Waldman A, Buckley C, Trigg W, Brooks DJ, Hinz R and
Edison P: Flutriciclamide (18F-GE180) PET: First-in-Human PET study
of novel third-generation in vivo marker of human translocator
protein. J Nucl Med. 57:1753–1759. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Chiabrando D, Marro S, Mercurio S, Giorgi
C, Petrillo S, Vinchi F, Fiorito V, Fagoonee S, Camporeale A, Turco
E, et al: The mitochondrial heme exporter FLVCR1b mediates
erythroid differentiation. J Clin Invest. 122:4569–4579. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Ni R, Rojdner J, Voytenko L, Dyrks T,
Thiele A, Marutle A and Nordberg A: In vitro characterization of
the regional binding distribution of amyloid PET tracer florbetaben
and the glia tracers deprenyl and PK11195 in Autopsy Alzheimer's
brain tissue. J Alzheimers Dis. 80:1723–1737. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Ishikawa M, Yoshitomi T, Covey DF,
Zorumski CF and Izumi Y: TSPO activation modulates the effects of
high pressure in a rat ex vivo glaucoma model. Neuropharmacology.
111:142–159. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Papadopoulos V and Lecanu L: Translocator
protein (18 kDa) TSPO: An emerging therapeutic target in
neurotrauma. Exp Neurol. 219:53–57. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Girard C, Liu S, Adams D, Lacroix C,
Sinéus M, Boucher C, Papadopoulos V, Rupprecht R, Schumacher M and
Groyer G: Axonal regeneration and neuroinflammation: Roles for the
translocator protein 18 kDa. J Neuroendocrinol. 24:71–81. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Ravikumar B, Crawford D, Dellovade T,
Savinainen A, Graham D, Liere P, Oudinet JP, Webb M and Hering H:
Differential efficacy of the TSPO ligands etifoxine and XBD-173 in
two rodent models of Multiple Sclerosis. Neuropharmacology.
108:229–237. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Choi HB, Khoo C, Ryu JK, van Breemen E,
Kim SU and McLarnon JG: Inhibition of lipopolysaccharide-induced
cyclooxygenase-2, tumor necrosis factor-alpha and [Ca2+]i responses
in human microglia by the peripheral benzodiazepine receptor ligand
PK11195. J Neurochem. 83:546–555. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Lebedeva IV, Su ZZ, Sarkar D, Kitada S,
Dent P, Waxman S, Reed JC and Fisher PB: Melanoma differentiation
associated gene-7, mda-7/interleukin-24, induces apoptosis in
prostate cancer cells by promoting mitochondrial dysfunction and
inducing reactive oxygen species. Cancer Res. 63:8138–8144.
2003.PubMed/NCBI
|
|
63
|
Seneviratne MS, Faccenda D, De Biase V and
Campanella M: PK11195 inhibits mitophagy targeting the
F1Fo-ATPsynthase in Bcl-2 knock-down cells. Curr Mol Med.
12:476–482. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Bonora M, Giorgi C and Pinton P: Molecular
mechanisms and consequences of mitochondrial permeability
transition. Nat Rev Mol Cell Biol. 23:266–285. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Gonzalez-Polo RA, Carvalho G, Braun T,
Decaudin D, Fabre C, Larochette N, Perfettini JL, Djavaheri-Mergny
M, Youlyouz-Marfak I, Codogno P, et al: PK11195 potently sensitizes
to apoptosis induction independently from the peripheral
benzodiazepin receptor. Oncogene. 24:7503–7513. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Choi J, Ifuku M, Noda M and Guilarte TR:
Translocator protein (18 kDa)/peripheral benzodiazepine receptor
specific ligands induce microglia functions consistent with an
activated state. Glia. 59:219–230. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Awad M and Gavish M: Binding of [3H]Ro
5-4864 and [3H]PK 11195 to cerebral cortex and peripheral tissues
of various species: Species differences and heterogeneity in
peripheral benzodiazepine binding sites. J Neurochem. 49:1407–1414.
1987. View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Marangos PJ, Patel J, Boulenger JP and
Clark-Rosenberg R: Characterization of peripheral-type
benzodiazepine binding sites in brain using [3H]Ro 5-4864. Mol
Pharmacol. 22:26–32. 1982.PubMed/NCBI
|
|
69
|
Kreisl WC, Kim MJ, Coughlin JM, Henter ID,
Owen DR and Innis RB: PET imaging of neuroinflammation in
neurological disorders. Lancet Neurol. 19:940–950. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Gut P, Baeza-Raja B, Andersson O,
Hasenkamp L, Hsiao J, Hesselson D, Akassoglou K, Verdin E, Hirschey
MD and Stainier DY: Whole-organism screening for gluconeogenesis
identifies activators of fasting metabolism. Nat Chem Biol.
9:97–104. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Da Pozzo E, Giacomelli C, Barresi E, Costa
B, Taliani S, Passetti Fda S and Martini C: Targeting the 18-kDa
translocator protein: recent perspectives for neuroprotection.
Biochem Soc Trans. 43:559–565. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
72
|
Gavioli EC, Duarte FS, Bressan E, Ferrara
P, Farges RC and De Lima TC: Antidepressant-like effect of
Ro5-4864, a peripheral-type benzodiazepine receptor ligand, in
forced swimming test. Eur J Pharmacol. 471:21–26. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Kita A, Kohayakawa H, Kinoshita T, Ochi Y,
Nakamichi K, Kurumiya S, Furukawa K and Oka M: Antianxiety and
antidepressant-like effects of AC-5216, a novel mitochondrial
benzodiazepine receptor ligand. Br J Pharmacol. 142:1059–1072.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
74
|
Baez E, Guio-Vega GP, Echeverria V,
Sandoval-Rueda DA and Barreto GE: 4′-chlorodiazepam protects
mitochondria in T98G astrocyte cell line from glucose deprivation.
Neurotox Res. 32:163–171. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
75
|
Nothdurfter C, Rammes G, Baghai TC, Schüle
C, Schumacher M, Papadopoulos V and Rupprecht R: Translocator
protein (18 kDa) as a target for novel anxiolytics with a
favourable side-effect profile. J Neuroendocrinol. 24:82–92. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
76
|
Kita A, Kinoshita T, Kohayakawa H,
Furukawa K and Akaike A: Lack of tolerance to anxiolysis and
withdrawal symptoms in mice repeatedly treated with AC-5216, a
selective TSPO ligand. Prog Neuropsychopharmacol Biol Psychiatry.
33:1040–1045. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
77
|
Karlstetter M, Nothdurfter C, Aslanidis A,
Moeller K, Horn F, Scholz R, Neumann H, Weber BH, Rupprecht R and
Langmann T: Translocator protein (18 kDa) (TSPO) is expressed in
reactive retinal microglia and modulates microglial inflammation
and phagocytosis. J Neuroinflammation. 11:32014. View Article : Google Scholar : PubMed/NCBI
|
|
78
|
Scholz R, Caramoy A, Bhuckory MB, Rashid
K, Chen M, Xu H, Grimm C and Langmann T: Targeting translocator
protein (18 kDa) (TSPO) dampens pro-inflammatory microglia
reactivity in the retina and protects from degeneration. J
Neuroinflammation. 12:2012015. View Article : Google Scholar : PubMed/NCBI
|
|
79
|
Schlichter R, Rybalchenko V, Poisbeau P,
Verleye M and Gillardin J: Modulation of GABAergic synaptic
transmission by the non-benzodiazepine anxiolytic etifoxine.
Neuropharmacology. 39:1523–1535. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
80
|
Choi YM and Kim KH: Etifoxine for pain
patients with anxiety. Korean J Pain. 28:4–10. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
81
|
Girard C, Liu S, Cadepond F, Adams D,
Lacroix C, Verleye M, Gillardin JM, Baulieu EE, Schumacher M and
Schweizer-Groyer G: Etifoxine improves peripheral nerve
regeneration and functional recovery. Proc Natl Acad Sci USA.
105:20505–20510. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
82
|
Olsen RW and Li GD: GABA(A) receptors as
molecular targets of general anesthetics: Identification of binding
sites provides clues to allosteric modulation. Can J Anaesth.
58:206–215. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
83
|
Gunn BG, Brown AR, Lambert JJ and Belelli
D: Neurosteroids and GABA(A) Receptor Interactions: A focus on
stress. Front Neurosci. 5:1312011. View Article : Google Scholar : PubMed/NCBI
|
|
84
|
Biswas L, Ibrahim KS, Li X, Zhou X, Zeng
Z, Craft J and Shu X: Effect of a TSPO ligand on retinal pigment
epithelial cholesterol homeostasis in high-fat fed mice,
implication for age-related macular degeneration. Exp Eye Res.
208:1086252021. View Article : Google Scholar : PubMed/NCBI
|
|
85
|
Ibrahim KS, Craft JA, Biswas L, Spencer J
and Shu X: Etifoxine reverses weight gain and alters the colonic
bacterial community in a mouse model of obesity. Biochem Pharmacol.
180:1141512020. View Article : Google Scholar : PubMed/NCBI
|
|
86
|
Costa B, Cavallini C, Da Pozzo E, Taliani
S, Da Settimo F and Martini C: The anxiolytic etifoxine binds to
TSPO Ro5-4864 binding site with long residence time showing a high
neurosteroidogenic activity. ACS Chem Neurosci. 8:1448–1454. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
87
|
Kondo D, Saegusa H, Yabe R, Takasaki I,
Kurihara T, Zong S and Tanabe T: Peripheral-type benzodiazepine
receptor antagonist is effective in relieving neuropathic pain in
mice. J Pharmacol Sci. 110:55–63. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
88
|
Tsukagoshi E, Kawaguchi M, Shinomiya T,
Yoshikawa M, Kawano T, Okubo M and Sawaki K: Diazepam enhances
production of diazepam-binding inhibitor (DBI), a negative saliva
secretion regulator, localized in rat salivary gland. J Pharmacol
Sci. 115:221–229. 2011. View Article : Google Scholar
|
|
89
|
Morin D, Musman J, Pons S, Berdeaux A and
Ghaleh B: Mitochondrial translocator protein (TSPO): From
physiology to cardioprotection. Biochem Pharmacol. 105:1–13. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
90
|
Leducq N, Bono F, Sulpice T, Vin V, Janiak
P, Fur GL, O'Connor SE and Herbert JM: Role of peripheral
benzodiazepine receptors in mitochondrial, cellular, and cardiac
damage induced by oxidative stress and ischemia-reperfusion. J
Pharmacol Exp Ther. 306:828–837. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
91
|
Santoro A, Mattace Raso G, Taliani S, Da
Pozzo E, Simorini F, Costa B, Martini C, Laneri S, Sacchi A,
Cosimelli B, et al: TSPO-ligands prevent oxidative damage and
inflammatory response in C6 glioma cells by neurosteroid synthesis.
Eur J Pharm Sci. 88:124–131. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
92
|
Klee K, Storti F, Barben M, Samardzija M,
Langmann T, Dunaief J and Grimm C: Systemic knockout of Tspo in
mice does not affect retinal morphology, function and
susceptibility to degeneration. Exp Eye Res. 188:1078162019.
View Article : Google Scholar : PubMed/NCBI
|
|
93
|
Storti F, Klee K, Todorova V, Steiner R,
Othman A, van der Velde-Visser S, Samardzija M, Meneau I, Barben M,
Karademir D, et al: Impaired ABCA1/ABCG1-mediated lipid efflux in
the mouse retinal pigment epithelium (RPE) leads to retinal
degeneration. Elife. 8:e451002019. View Article : Google Scholar : PubMed/NCBI
|
|
94
|
Santos AM, Calvente R, Tassi M, Carrasco
MC, Martín-Oliva D, Marín-Teva JL, Navascués J and Cuadros MA:
Embryonic and postnatal development of microglial cells in the
mouse retina. J Comp Neurol. 506:224–239. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
95
|
Lee MA, Sitko AA, Khalid S, Shirasu-Hiza M
and Mason CA: Spatiotemporal distribution of glia in and around the
developing mouse optic tract. J Comp Neurol. 527:508–521. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
96
|
Stevens B, Allen NJ, Vazquez LE, Howell
GR, Christopherson KS, Nouri N, Micheva KD, Mehalow AK, Huberman
AD, Stafford B, et al: The classical complement cascade mediates
CNS synapse elimination. Cell. 131:1164–1178. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
97
|
Prinz M and Mildner A: Microglia in the
CNS: Immigrants from another world. Glia. 59:177–187. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
98
|
Banati RB, Middleton RJ, Chan R, Hatty CR,
Kam WW, Quin C, Graeber MB, Parmar A, Zahra D, Callaghan P, et al:
Positron emission tomography and functional characterization of a
complete PBR/TSPO knockout. Nat Commun. 5:54522014. View Article : Google Scholar : PubMed/NCBI
|
|
99
|
Barron AM, Ji B, Kito S, Suhara T and
Higuchi M: Steroidogenic abnormalities in translocator protein
knockout mice and significance in the aging male. Biochem J.
475:75–85. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
100
|
Grassmann F, Fauser S and Weber BH: The
genetics of age-related macular degeneration (AMD)-Novel targets
for designing treatment options? Eur J Pharm Biopharm. 95:194–202.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
101
|
Csader S, Korhonen S, Kaarniranta K and
Schwab U: The effect of dietary supplementations on delaying the
progression of age-related macular degeneration: A systematic
review and meta-analysis. Nutrients. 14:42732022. View Article : Google Scholar : PubMed/NCBI
|
|
102
|
Fleckenstein M, Keenan TDL, Guymer RH,
Chakravarthy U, Schmitz-Valckenberg S, Klaver CC, Wong WT and Chew
EY: Age-related macular degeneration. Nat Rev Dis Primers.
7:312021. View Article : Google Scholar : PubMed/NCBI
|
|
103
|
Pikuleva IA and Curcio CA: Cholesterol in
the retina: The best is yet to come. Prog Retin Eye Res. 41:64–89.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
104
|
Curcio CA, Presley JB, Malek G, Medeiros
NE, Avery DV and Kruth HS: Esterified and unesterified cholesterol
in drusen and basal deposits of eyes with age-related maculopathy.
Exp Eye Res. 81:731–741. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
105
|
Bhutto I and Lutty G: Understanding
age-related macular degeneration (AMD): Relationships between the
photoreceptor/retinal pigment epithelium/Bruch's
membrane/choriocapillaris complex. Mol Aspects Med. 33:295–317.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
106
|
Biesemeier A, Taubitz T, Julien S, Yoeruek
E and Schraermeyer U: Choriocapillaris breakdown precedes retinal
degeneration in age-related macular degeneration. Neurobiol Aging.
35:2562–2573. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
107
|
Fritsche LG, Igl W, Bailey JN, Grassmann
F, Sengupta S, Bragg-Gresham JL, Burdon KP, Hebbring SJ, Wen C,
Gorski M, et al: A large genome-wide association study of
age-related macular degeneration highlights contributions of rare
and common variants. Nat Genet. 48:134–143. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
108
|
Toomey CB, Johnson LV and Bowes Rickman C:
Complement factor H in AMD: Bridging genetic associations and
pathobiology. Prog Retin Eye Res. 62:38–57. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
109
|
Malek G, Johnson LV, Mace BE, Saloupis P,
Schmechel DE, Rickman DW, Toth CA, Sullivan PM and Bowes Rickman C:
Apolipoprotein E allele-dependent pathogenesis: A model for
age-related retinal degeneration. Proc Natl Acad Sci USA.
102:11900–11905. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
110
|
Toomey CB, Kelly U, Saban DR and Bowes
Rickman C: Regulation of age-related macular degeneration-like
pathology by complement factor H. Proc Natl Acad Sci USA.
112:E3040–E3049. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
111
|
Langmann T: Microglia activation in
retinal degeneration. J Leukoc Biol. 81:1345–1351. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
112
|
Zeng H, Ding M, Chen XX and Lu Q:
Microglial NADPH oxidase activation mediates rod cell death in the
retinal degeneration in rd mice. Neuroscience. 275:54–61. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
113
|
Zhao L, Zabel MK, Wang X, Ma W, Shah P,
Fariss RN, Qian H, Parkhurst CN, Gan WB and Wong WT: Microglial
phagocytosis of living photoreceptors contributes to inherited
retinal degeneration. EMBO Mol Med. 7:1179–1197. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
114
|
Farhan F, Almarhoun M, Wong A, Findlay AS,
Bartholomew C, Williams MTS, Hurd TW and Shu X: Deletion of TSPO
causes dysregulation of cholesterol metabolism in mouse retina.
Cells. 10:30662021. View Article : Google Scholar : PubMed/NCBI
|
|
115
|
Luckoff A, Scholz R, Sennlaub F, Xu H and
Langmann T: Comprehensive analysis of mouse retinal mononuclear
phagocytes. Nat Protoc. 12:1136–1150. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
116
|
Nagineni CN, Kommineni VK, William A,
Detrick B and Hooks JJ: Regulation of VEGF expression in human
retinal cells by cytokines: implications for the role of
inflammation in age-related macular degeneration. J Cell Physiol.
227:116–126. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
117
|
Osborne NN, Casson RJ, Wood JP, Chidlow G,
Graham M and Melena J: Retinal ischemia: Mechanisms of damage and
potential therapeutic strategies. Prog Retin Eye Res. 23:91–147.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
118
|
Osborne NN, Ugarte M, Chao M, Chidlow G,
Bae JH, Wood JP and Nash MS: Neuroprotection in relation to retinal
ischemia and relevance to glaucoma. Surv Ophthalmol. 43 (Suppl
1):S102–S128. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
119
|
Youngblood H, Robinson R, Sharma A and
Sharma S: Proteomic biomarkers of retinal inflammation in diabetic
retinopathy. Int J Mol Sci. 20:47552019. View Article : Google Scholar : PubMed/NCBI
|
|
120
|
Khayat M, Williams M and Lois N: Ischemic
retinal vein occlusion: Characterizing the more severe spectrum of
retinal vein occlusion. Surv Ophthalmol. 63:816–850. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
121
|
Heyck M, Bonsack B, Zhang H, Sadanandan N,
Cozene B, Kingsbury C, Lee JY and Borlongan CV: The brain and eye:
Treating cerebral and retinal ischemia through mitochondrial
transfer. Exp Biol Med (Maywood). 244:1485–1492. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
122
|
Liu GJ, Middleton RJ, Kam WW, Chin DY,
Hatty CR, Chan RH and Banati RB: Functional gains in energy and
cell metabolism after TSPO gene insertion. Cell Cycle. 16:436–447.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
123
|
Lieth E, Barber AJ, Xu B, Dice C, Ratz MJ,
Tanase D and Strother JM: Glial reactivity and impaired glutamate
metabolism in short-term experimental diabetic retinopathy. Penn
State Retina Research Group. Diabetes. 47:815–820. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
124
|
Wagner L, Pannicke T, Rupprecht V,
Frommherz I, Volz C, Illes P, Hirrlinger J, Jägle H, Egger V,
Haydon PG, et al: Suppression of SNARE-dependent exocytosis in
retinal glial cells and its effect on ischemia-induced
neurodegeneration. Glia. 65:1059–1071. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
125
|
Dkhissi O, Chanut E, Wasowicz M,
Savoldelli M, Nguyen-Legros J, Minvielle F and Versaux-Botteri C:
Retinal TUNEL-positive cells and high glutamate levels in vitreous
humor of mutant quail with a glaucoma-like disorder. Invest
Ophthalmol Vis Sci. 40:990–995. 1999.PubMed/NCBI
|
|
126
|
Delyfer MN, Forster V, Neveux N, Picaud S,
Leveillard T and Sahel JA: Evidence for glutamate-mediated
excitotoxic mechanisms during photoreceptor degeneration in the rd1
mouse retina. Mol Vis. 11:688–696. 2005.PubMed/NCBI
|
|
127
|
Vujosevic S, Aldington SJ, Silva P,
Hernández C, Scanlon P, Peto T and Simó R: Screening for diabetic
retinopathy: New perspectives and challenges. Lancet Diabetes
Endocrinol. 8:337–347. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
128
|
Wang W and Lo ACY: Diabetic retinopathy:
Pathophysiology and treatments. Int J Mol Sci. 19:18162018.
View Article : Google Scholar : PubMed/NCBI
|
|
129
|
Fung TH, Patel B, Wilmot EG and Amoaku WM:
Diabetic retinopathy for the non-ophthalmologist. Clin Med (Lond).
22:112–116. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
130
|
Brownlee M: The pathobiology of diabetic
complications: A unifying mechanism. Diabetes. 54:1615–1625. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
131
|
Naruse K, Nakamura J, Hamada Y, Nakayama
M, Chaya S, Komori T, Kato K, Kasuya Y, Miwa K and Hotta N: Aldose
reductase inhibition prevents glucose-induced apoptosis in cultured
bovine retinal microvascular pericytes. Exp Eye Res. 71:309–315.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
132
|
Romeo G, Liu WH, Asnaghi V, Kern TS and
Lorenzi M: Activation of nuclear factor-kappaB induced by diabetes
and high glucose regulates a proapoptotic program in retinal
pericytes. Diabetes. 51:2241–2248. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
133
|
Abcouwer SF: Muller cell-microglia cross
talk drives neuroinflammation in diabetic retinopathy. Diabetes.
66:261–263. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
134
|
Sorrentino FS, Allkabes M, Salsini G,
Bonifazzi C and Perri P: The importance of glial cells in the
homeostasis of the retinal microenvironment and their pivotal role
in the course of diabetic retinopathy. Life Sci. 162:54–59. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
135
|
Podesta F, Romeo G, Liu WH, Krajewski S,
Reed JC, Gerhardinger C and Lorenzi M: Bax is increased in the
retina of diabetic subjects and is associated with pericyte
apoptosis in vivo and in vitro. Am J Pathol. 156:1025–1032. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
136
|
Tien T, Zhang J, Muto T, Kim D, Sarthy VP
and Roy S: High glucose induces mitochondrial dysfunction in
retinal muller cells: Implications for diabetic retinopathy. Invest
Ophthalmol Vis Sci. 58:2915–2921. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
137
|
Sasaki M, Ozawa Y, Kurihara T, Kubota S,
Yuki K, Noda K, Kobayashi S, Ishida S and Tsubota K:
Neurodegenerative influence of oxidative stress in the retina of a
murine model of diabetes. Diabetologia. 53:971–979. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
138
|
Li J and Papadopoulos V: Translocator
protein (18 kDa) as a pharmacological target in adipocytes to
regulate glucose homeostasis. Biochem Pharmacol. 97:99–110. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
139
|
Musman J, Paradis S, Panel M, Pons S,
Barau C, Caccia C, Leoni V, Ghaleh B and Morin D: A TSPO ligand
prevents mitochondrial sterol accumulation and dysfunction during
myocardial ischemia-reperfusion in hypercholesterolemic rats.
Biochem Pharmacol. 142:87–95. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
140
|
Ciudin A, Simo-Servat O, Hernandez C,
Arcos G, Diego S, Sanabria Á, Sotolongo Ó, Hernández I, Boada M and
Simó R: Retinal Microperimetry: A new tool for identifying patients
with type 2 diabetes at risk for developing Alzheimer disease.
Diabetes. 66:3098–3104. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
141
|
Kinuthia UM, Wolf A and Langmann T:
Microglia and inflammatory responses in diabetic retinopathy. Front
Immunol. 11:5640772020. View Article : Google Scholar : PubMed/NCBI
|
|
142
|
Flaxman SR, Bourne RRA, Resnikoff S,
Ackland P, Braithwaite T, Cicinelli MV, Das A, Jonas JB, Keeffe J,
Kempen JH, et al: Global causes of blindness and distance vision
impairment 1990–2020: A systematic review and meta-analysis. Lancet
Glob Health. 5:e1221–e1234. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
143
|
Tham YC, Li X, Wong TY, Quigley HA, Aung T
and Cheng CY: Global prevalence of glaucoma and projections of
glaucoma burden through 2040: A systematic review and
meta-analysis. Ophthalmology. 121:2081–2090. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
144
|
Zukerman R, Harris A, Oddone F, Siesky B,
Verticchio Vercellin A and Ciulla TA: Glaucoma heritability:
Molecular mechanisms of disease. Genes (Basel). 12:11352021.
View Article : Google Scholar : PubMed/NCBI
|
|
145
|
Quigley HA: Glaucoma. Lancet.
377:1367–1377. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
146
|
Ishikawa M, Yoshitomi T, Zorumski CF and
Izumi Y: Neurosteroids are endogenous neuroprotectants in an ex
vivo glaucoma model. Invest Ophthalmol Vis Sci. 55:8531–8541. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
147
|
Belelli D and Lambert JJ: Neurosteroids:
endogenous regulators of the GABA(A) receptor. Nat Rev Neurosci.
6:565–575. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
148
|
Weir CJ, Ling AT, Belelli D, Wildsmith JA,
Peters JA and Lambert JJ: The interaction of anaesthetic steroids
with recombinant glycine and GABAA receptors. Br J Anaesth.
92:704–711. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
149
|
Midzak A, Akula N, Lecanu L and
Papadopoulos V: Novel androstenetriol interacts with the
mitochondrial translocator protein and controls steroidogenesis. J
Biol Chem. 286:9875–9887. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
150
|
Izumi Y, Benz AM, Kurby CO, Labruyere J,
Zorumski CF, Price MT and Olney JW: An ex vivo rat retinal
preparation for excitotoxicity studies. J Neurosci Methods.
60:219–225. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
151
|
Izumi Y, Kirby CO, Benz AM, Olney JW and
Zorumski CF: Muller cell swelling, glutamate uptake, and
excitotoxic neurodegeneration in the isolated rat retina. Glia.
25:379–389. 1999. View Article : Google Scholar : PubMed/NCBI
|
